Advertisement

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Barbara Wassmann, Heike Pfeifer, Michael Stadler, Martin Bornhaüser, Gesine Bug, Urban J. Scheuring, Patrick Brück, Matthias Stelljes, Rainer Schwerdtfeger, Nadezda Basara, Jolanta Perz, Donald Bunjes, Georg Ledderose, Rolf Mahlberg, Anja Binckebanck, Harald Gschaidmeier, Dieter Hoelzer and Oliver G. Ottmann

Article Information

Citation 
vol. 106 no. 2 458-463
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted May 13, 2004
  • Accepted March 1, 2005
  • Published online July 1, 2005.


Contributors 
  • Barbara Wassmann
  • Heike Pfeifer
  • Michael Stadler
  • Martin Bornhaüser
  • Gesine Bug
  • Urban J. Scheuring
  • Patrick Brück
  • Matthias Stelljes
  • Rainer Schwerdtfeger
  • Nadezda Basara
  • Jolanta Perz
  • Donald Bunjes
  • Georg Ledderose
  • Rolf Mahlberg
  • Anja Binckebanck
  • Harald Gschaidmeier
  • Dieter Hoelzer
  • Oliver G. Ottmann

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output